Patient-Reported Outcomes in Virologically Suppressed, HIV-1–Infected Subjects After Switching to a Simplified, Single-Tablet Regimen of Efavirenz, Emtricitabine, and Tenofovir DF

2010 ◽  
Vol 24 (2) ◽  
pp. 87-96 ◽  
Author(s):  
Sally L. Hodder ◽  
Karam Mounzer ◽  
Edwin DeJesus ◽  
Ramin Ebrahimi ◽  
Kristy Grimm ◽  
...  
Keyword(s):  
Patient Reported Outcomes ◽  
Single Tablet Regimen ◽  
Patient Reported ◽  
Tenofovir Df ◽  
Hiv 1

scholarly journals Correction to: Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression

2020 ◽  
Vol 13 (4) ◽  
pp. 469-470
Author(s):  
Andrea Antinori ◽  
Maria V. Cossu ◽  
Barbara Menzaghi ◽  
Gaetana Sterrantino ◽  
Nicola Squillace ◽  
...  
Keyword(s):  
Patient Reported Outcomes ◽  
Viral Suppression ◽  
Patient Reported ◽  
Observational Cohort ◽  
Hiv 1

scholarly journals Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression

2020 ◽  
Vol 13 (3) ◽  
pp. 375-387
Author(s):  
Andrea Antinori ◽  
Maria V. Cossu ◽  
Barbara Menzaghi ◽  
Gaetana Sterrantino ◽  
Nicola Squillace ◽  
...  
Keyword(s):  
Patient Reported Outcomes ◽  
Viral Suppression ◽  
Patient Reported ◽  
Observational Cohort ◽  
Hiv 1

Patient-reported outcomes for HIV: the future of long-acting injectables and antiretroviral therapy evaluations

2021 ◽  
Author(s):  
Richard Leong ◽  
Leon Owusu ◽  
Jerrica Tang ◽  
Neeraj John ◽  
Kira E Voyer ◽  
...  
Keyword(s):  
Antiretroviral Therapy ◽  
Treatment Satisfaction ◽  
Patient Reported Outcomes ◽  
Potential Role ◽  
Drug Regimen ◽  
Patient Reported ◽  
Immunodeficiency Virus ◽  
Long Acting ◽  
Hiv 1 ◽  
Human Immunodeficiency Virus 1

Patient-reported outcomes (PROs) are an increasingly important aspect of patient care, as they offer a perspective from the patient themselves in the treatment and management of a particular disease state. They have a potential role in helping clinicians select an appropriate drug regimen in human immunodeficiency virus-1 (HIV-1)-infected individuals, as well as those with HIV/hepatitis C (HCV) co-infection. They can also provide insight for individuals receiving long-acting (LA) injectable antiretroviral therapy (ART). Studies found from PROs that participants on an LA injectable ART regimen reported greater preference and treatment satisfaction compared with those on an oral ART regimen. Some additional studies have also used PROs to evaluate the switch to single-tablet regimens and compare different ART in treating HIV-1. Current PROs and how they can be improved for LA injectables were also discussed.

scholarly journals Patient-reported outcomes and low-level residual HIV-RNA in adolescents perinatally infected with HIV-1 after switching to one-pill fixed-dose regimen

AIDS Care ◽  
2011 ◽  
Vol 24 (1) ◽  
pp. 54-58 ◽  
Author(s):  
Raffaella Rosso ◽  
Antonio Di Biagio ◽  
Franco Maggiolo ◽  
Loredana Nulvesu ◽  
Anna Paola Callegaro ◽  
...  
Keyword(s):  
Dose Regimen ◽  
Patient Reported Outcomes ◽  
Fixed Dose ◽  
Low Level ◽  
Hiv Rna ◽  
Patient Reported ◽  
Perinatally Infected ◽  
Hiv 1
Sign in / Sign up

Export Citation Format

Share Document